We have observed
13 EP applications
Jacobus Albertus Ronald Keus
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after February 25, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
LIVE ATTENUATED PARVOVIRUS
INFECTIOUS BRONCHITIS VIRUS (IBV) SPIKE PROTEIN AS SUBUNIT VACCINE
SALMONID ALPHAVIRUS VACCINE
AVIAN METAPNEUMOVIRUS IN ONCOLYSIS
PROTEIN FOR USE AS A MEDICAMENT
A RECOMBINANT KOI HERPESVIRUS (KHV) AND VACCINE FOR THE PREVENTION OF A DISEASE CAUSED BY KHV
SALMONID ALPHAVIRUS PROTEIN E2